Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 425
Selected: 0
NCT IDTitle
NCT00005062Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
NCT00004937Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
NCT00064207Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
NCT00043134Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
NCT00424164Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer
NCT03294746Imaging Biomarker in Cancer Drug Induced ILD
NCT02273271Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo
NCT00002549Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
NCT06219317Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC
NCT00003152Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT00004884Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
NCT06462963OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
NCT01795521LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC
NCT00003279Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00003642Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer
NCT02504372Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)
NCT06407401Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
NCT05904119Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
NCT00003031Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
NCT02866370Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
NCT00433563Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer
NCT00066339Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy
NCT00004934Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
NCT00041249Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT02343406Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas
NCT00002763High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
NCT01913652Ph II Cabazitaxel DD Liposarcoma
NCT02394626Surgery for Recurrent Glioblastoma
NCT00049595Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
NCT00003731Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
NCT06246149Adjuvant Tebentafusp in High Risk Ocular Melanoma
NCT01208064Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy
NCT00005052Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
NCT00021112Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
NCT03357224PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)
NCT00004179Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00047125Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
NCT03755856Long-term Outcomes for Acute Myeloid Leukemia Patients
NCT05209529Chemo-free BRCA-targeted Neoadjuvant Strategy
NCT00766779HCT Versus CT in Elderly AML
NCT00003029Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
NCT00646659Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
NCT00030680Radiation Therapy in Treating Patients With Aggressive Fibromatoses
NCT00005583Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer
NCT02507947SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access
NCT03609047Adjuvant Palbociclib in Elderly Patients With Breast Cancer
NCT01386398Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma
NCT00002899Adjuvant Radiation Therapy in Treating Patients With Brain Metastases
NCT00003758Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
NCT00003888Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer